Wind Lake, WI, United States of America

Allen Tsao

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Renotarget Therapeutics, Inc.. Active years: 2019.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Allen Tsao. Retrieved from https://idiyas.com/inventor/allen-tsao

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2019

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Allen Tsao: Innovator in Cancer Treatment

Introduction

Allen Tsao is a notable inventor based in Wind Lake, Wisconsin. He has made significant contributions to the field of cancer treatment through his innovative research and development of new therapeutic molecules.

Latest Patents

Allen Tsao holds a patent for a class of quinolone heterocyclic aromatic molecules aimed at cancer treatment. This invention, known as Renotinibs, is specifically designed to target cancers that harbor abnormal human epidermal growth factor receptors (EGFRs). His work in this area represents a promising advancement in oncology.

Career Highlights

Tsao's career is marked by his dedication to developing effective cancer therapies. He has successfully secured a patent, demonstrating his commitment to innovation in medical science. His work has the potential to improve treatment options for patients suffering from various forms of cancer.

Collaborations

Allen Tsao collaborates with talented professionals in his field, including Jujun Wang and Xiaomei Liu. These partnerships enhance the research and development process, fostering an environment of innovation and discovery.

Conclusion

Allen Tsao's contributions to cancer treatment through his patented inventions highlight his role as a key innovator in the medical field. His work continues to inspire advancements in therapeutic solutions for cancer patients.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…